Baseline characteristics for INFRONT 3: A Phase 3 double blind, placebo[...]
Notification Letter and Reply Form to Non registered Shareholders[...]
05/25/2022 | Press release | Distributed by Public on 05/25/2022 05:52
Please select the service you want to use:
Smartlinks | Safran SA | Company News | Shareholders | Shareholder Meeting | Business Announcement | Public Companies | Aerospace and Defense Companies | Borsa Italiana | London Stock Exchange (LSE) | Börse Frankfurt | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | OTC Markets | Tradegate Exchange | Turquoise | Euronext Paris | Börse Hamburg | Börse Hannover | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Börse Berlin Equiduct Trading | Aquis Exchange | SIGMA X MTF | EuroTLX | Euronext Block MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact